Comprehensive Relief: How to Help Ozempic Constipation and Support Your Journey

Last reviewed: May 15, 2026 Last updated: May 15, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

When you start GLP-1 weight loss therapy, your body undergoes significant metabolic shifts. One side effect many patients experience is constipation, which can affect your comfort and adherence to treatment. Understanding why this happens and knowing how to manage it can help you stay on track with your personalized weight loss plan.

Why GLP-1 Medications Slow Digestion

GLP-1 receptor agonists like semaglutide and tirzepatide work by signaling your brain that you're satisfied, reducing appetite and food intake. This powerful effect extends beyond appetite control—it also influences how quickly your stomach empties food into the small intestine, a process called gastric emptying. When gastric emptying slows, food moves more gradually through your digestive tract, which can lead to constipation as a natural physiological response.

The gut-brain axis plays a central role in this mechanism. Your gastrointestinal tract communicates with your brain through neural and hormonal pathways, and GLP-1 receptors are distributed throughout this entire system. When medication activates these receptors, it doesn't just suppress hunger—it also reduces the muscle contractions (peristalsis) that normally propel stool through your colon. This slowdown in intestinal motility, combined with reduced food volume and fluid intake, creates the perfect conditions for constipation to develop.

Research from the STEP and SURMOUNT clinical trials, which evaluated semaglutide and tirzepatide respectively, documented constipation as one of the most commonly reported gastrointestinal side effects. However, these trials also showed that most patients experience improvement over time as their bodies adapt to the medication. Knowing this is temporary can help you feel more confident pursuing targeted relief strategies.

How Gastric Emptying Changes Affect Your Bowel Function

Gastric emptying directly determines how quickly food and water reach your intestines. When GLP-1 medication slows this process, less water is available to soften stool in your colon. Harder, drier stool is significantly more difficult to pass, which explains why many patients on these medications experience both infrequent bowel movements and increased straining. This effect is dose-dependent: higher medication doses typically cause more pronounced slowing of gastric emptying.

The relationship between slower emptying and constipation isn't merely coincidental—it's a direct cause-and-effect chain. Additionally, because GLP-1 therapy reduces overall food intake, your digestive tract receives less bulk material to move along. Paradoxically, while you're eating less food (which aids weight loss), your intestines have less to work with to maintain normal bowel function. This is why fiber and hydration strategies become especially important during GLP-1 treatment, and why they often prove more effective than they might be in your pre-treatment baseline.

Recognizing Constipation Signs During GLP-1 Therapy

Not every change in bowel habits signals a problem requiring intervention. During GLP-1 treatment, it's normal to have fewer bowel movements than before medication because you're consuming significantly less food overall. The key distinction lies between a normal reduction in frequency and genuine constipation. Genuine medication-induced constipation involves hard, difficult-to-pass stool; persistent abdominal discomfort or bloating; or a feeling of incomplete evacuation even after bowel movements occur.

Pay attention to the duration and severity of your symptoms. Occasional mild constipation that resolves within a few days as your body adjusts is common and manageable. However, constipation lasting more than three days, accompanied by pain, blood in stool, or severe abdominal distension, warrants prompt communication with your PlexusDx clinician. Tracking your bowel movements and noting any changes in consistency, effort required, or associated discomfort creates a clear record that helps your healthcare provider tailor relief recommendations specifically to your situation.

Some patients experience constipation early in treatment (within the first 1-2 weeks), while others develop it gradually after several weeks. Timing matters because early-onset constipation often resolves without intervention as the body adapts, whereas later-onset constipation may indicate that your body needs additional support. Document when symptoms began and any patterns you notice—such as worse constipation on days when you eat less or drink less water—to provide your care team with valuable diagnostic information.

Evidence-Based Strategies to Relieve GLP-1-Related Constipation

Hydration is your first line of defense and requires deliberate attention during GLP-1 therapy. Because you're eating less, you may drink less automatically—yet adequate water intake is critical for softening stool and supporting healthy intestinal motility. Aim for a minimum of 8-10 glasses of water daily, and increase this amount if you exercise, live in a dry climate, or experience constipation. Herbal teas, broths, and other non-caffeinated beverages contribute to hydration, though water remains the most effective option. Some patients find that spreading fluid intake throughout the day prevents the bloating that concentrated fluid consumption can trigger.

Dietary fiber becomes increasingly important—but must be introduced gradually. Soluble fiber sources like psyllium husk, ground flaxseed, chia seeds, and oat bran absorb water and add bulk to stool in a gentler way than insoluble fiber. Start with one teaspoon of ground flaxseed mixed into yogurt or smoothies, then gradually increase over one week. Insoluble fiber sources like whole grains, leafy greens, and vegetable skins should be introduced slowly as well, since too much fiber too quickly can cause bloating and gas—especially on a reduced-calorie diet. The goal is consistent, sustainable fiber intake rather than dramatic increases.

Movement and physical activity directly stimulate intestinal motility. Even light exercise like a 15-20 minute walk after meals can trigger natural peristalsis and encourage bowel movements. Yoga poses that gently massage the abdomen (like cat-cow stretches or child's pose) may provide additional benefit. If you're new to exercise, start conservatively and increase gradually alongside your GLP-1 dose escalation. Additionally, establishing a consistent bathroom routine—sitting on the toilet at the same time each day, ideally 20-30 minutes after a meal—helps train your body's natural reflexes and can be surprisingly effective even when no urge is present.

When to Reach Out to Your PlexusDx Care Team

Contact your clinician if constipation persists beyond one week despite implementing hydration, fiber, and movement strategies, or if you experience severe abdominal pain, bleeding, or signs of intestinal obstruction (persistent vomiting, inability to pass gas, or extreme distension). Your PlexusDx team can evaluate whether your current medication dose needs adjustment, whether a specific underlying condition is contributing, or whether prescription-strength interventions like lubiprostone or linaclotide might be appropriate. Some patients benefit from temporary dose reduction while their body adjusts, followed by gradual escalation—a strategy your clinician can customize to your needs.

PlexusDx's Precision Peptide Genetic Test reveals individual predispositions in peptide genetic pathways that influence how your body responds to GLP-1 therapy. Understanding your genetic profile for markers like GLP1R rs6923761 and MC4R rs17782313 can help your care team predict whether you're likely to experience stronger gastrointestinal effects and proactively design a management plan. This personalized approach means your relief strategy isn't one-size-fits-all—it's calibrated to your unique biology, making constipation management part of your overall precision weight loss journey with PlexusDx.

Frequently Asked Questions About Comprehensive Relief: How to Help Ozempic Constipation and Support Your Journey

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.